BNET Industries

Market Cap:$328.2M
Last Fiscal Year Sales:$9.8M
  • Public
  • US
Dow Jones Description

We are a clinical-stage biopharmaceutical company committed to discovering and developing innovative therapies offering significant medical advances and new options for patients. We are focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Our lead drug candidate, lorcaserin hydrochloride, or lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Our broad pipeline of novel compounds targets G protein-coupled receptors, or GPCRs, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc., or Merck, and Ortho-McNeil-Janssen Pharmaceuticals, Inc., or Ortho-McNeil-Janssen. We focus on GPCRs because they are a validated class of drug targets that mediate the majority of cell-to-cell communication in humans. A high percentage of todays prescription drugs target one or more GPCRs, and we believe that approved GPCR-based drugs target only approximately one third of the known non-sensory GPCRs. Selective targeting of specific GPCRs is intended to increase the likelihood of the desired pharmacology and minimize the risk of off target effects. We believe our GPCR-focused technologies and integrated discovery and development capabilities will allow us to continue to build our pipeline of unique and selective drug candidates. ...

Co-Founder, Chairman, President and Chief Executive Officer
Jack Lief
Number of Employees 499
Contact Information

6166 Nancy Ridge Dr

San Diego, California 92121-3223

arenapharm.com

(858) 453-7200

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Arena Pharmaceuticals, Inc. ARNA Announces Third Quarter 2009 Financial Results and Recent Developments

    11/10/09 - Financial Announcement - View Story

  • Morning Movers 9/15: LXRX, AMTY, DIET, DARA, BCRX Higher; ZOOM, NTWK, GRT, ARNA Lower

    9/15/09 - Bond / Stock Rating - View Story

  • Rodman and Renshaw Downgrades Arena Pharma ARNA to Market Perform

    9/15/09 - Bond / Stock Rating - View Story

  • Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments

    8/03/09 - Financial Announcement - View Story

News & Analysis

arena pharmaceuticals inc. and derek lowe - All News and Analysis

Decision Makers

Name (plus bio) Position
Dominic P. Behan Co-Founder, Director, Senior Vice President and Chief Scientific Officer
Robert E. Hoffman Vice President, Finance and Chief Financial Officer
William Shanahan Vice President & Chief Medical Officer
Steven Spector Senior Vice President, General Counsel and Secretary
K. A. Ajit-Simh Vice President, Quality Sys
K. Smith Vice President, Quality Systems
Louis J. Xcotti Vice President, Business Development & Marketing
Louis Scotti Vice President, Marketing and Business Development
Derek Chalmers Co-Founder
David Walsey Director, Corporate Communications
J Clayburn La
James E Flynn
Clayburn Force Director
Harry F. Hixson Director
J. Clayburn La Force Director
Tina S. Nova Director
Donald D. Belcher Member
Scott H. Bice Member

Board of Directors

Name (plus bio) Position
Jack Lief Co-Founder, Chairman, President and Chief Executive Officer
Christine A. White Board of Directors
Phillip M. Schneider Board of Directors
Randall E Woods Board of Directors
Robert L. Toms Board of Directors
Tina Nova Bennett Board of Directors

Jack Lief is a co-founder of Arena and has served as a director and our President and Chief Executive Officer since April 1997. Mr. Lief has also served as the Chairman of our Board of Directors since October 2007. From 1995 to April 1997, Mr. Lief served as an advisor and consultant to numerous biopharmaceutical organizations. From 1989 to 1994, Mr. Lief served as Senior Vice President, Corporate Development and Secretary of Cephalon, Inc., a biopharmaceutical company. From 1983 to 1989, Mr. Lief served as Director of Business Development and Strategic Planning for Alpha Therapeutic Corporation, a manufacturer of biological products. Mr. Lief joined Abbott Laboratories, a pharmaceutical company, in 1972, where he served until 1983, most recently as the head of International Marketing Research. Mr. Lief serves as a member of the board of directors of Adventrx Pharmaceuticals, Inc., a research and development company focused on pharmaceuticals for cancer and infectious disease. Mr. Lief is also an Executive Board Member of BIOCOM, a life science industry association representing more than 550 member companies in Southern California, and was the Chairman of the board of directors of BIOCOM from March 2005 to March 2006. Mr. Lief holds a B.A. from Rutgers University and an M.S. in Psychology (Experimental and Neurobiology) from Lehigh University.

Organization Position Status
Arena Pharmaceuticals, Inc. Co-Founder, Chairman, President and Chief Executive Officer Current
A-R-E-N-A.Com Co-Founder Current
Adventrx Pharmaceuticals Inc Chairman Current
Biocom, Inc. Executive Board Member Current
Southern California Inc Board of Directors Current
Cephalon, Inc. Senior Vice President, Corporate Development Former
Biocom, Inc. Chairman Former
Arena Pharmaceuticals, Inc. Board of Directors Former
Adventrx Pharmaceuticals Inc Board of Directors Former
Cephalon, Inc. Secretary Former
Rutgers University B.A. Former

Dominic P. Behan, Ph.D., is a co-founder of Arena and has served as a director since April 2000, and as our Senior Vice President and Chief Scientific Officer since June 2004. Dr. Behan served as our Vice President, Research from April 1997 to June 2004. From 1993 to January 1997, Dr. Behan directed various research programs at Neurocrine Biosciences, Inc., a biopharmaceutical company. From 1990 to 1993, Dr. Behan was engaged in research at the Salk Institute. Dr. Behan holds a B.Sc. in Biochemistry from Leeds University, England, and a Ph.D. in Biochemistry from Reading University, England.

Organization Position Status
Arena Pharmaceuticals, Inc. Co-Founder, Director, Senior Vice President and Chief Scientific Officer Current
A-R-E-N-A.Com Co-Founder Current
Arena Pharmaceuticals, Inc. Director Current
Salk Institute Former
Neurocrine Biosciences, Inc. Former
Reading University Ph.D. In Biochemistry Former
Leeds University B.Sc. In Biochemistry Former

Robert E. Hoffman, C.P.A., has served as our Vice President, Finance and Chief Financial Officer since December 2005. Mr. Hoffman served as our Vice President, Finance and Chief Accounting Officer from June 2004 to December 2005, as our Vice President, Finance from April 2000 to June 2004, and as our Controller from August 1997 to April 2000. From 1994 to 1997, Mr. Hoffman served as Assistant Controller for Document Sciences Corporation, a software company. Mr. Hoffman serves as a member of the steering committee of the Association of Bioscience Financial Officers and as a supervisory committee member of the San Diego County Credit Union. He is also a director and a former President of the San Diego chapter of Financial Executives International. Mr. Hoffman holds a B.B.A. from St. Bonaventure University and is licensed as a C.P.A. in the State of California.

Organization Position Status
Arena Pharmaceuticals, Inc. Vice President, Finance and Chief Financial Officer Current
Arena Pharmaceuticals, Inc. Board of Directors Current
Document Sciences Corporation Assistant Controller Former
St. Bonaventure University B.B.A. Former

William R. Shanahan, Jr., M.D., J.D., has served as our Vice President and Chief Medical Officer since March 2004. From August 2000 to March 2004, Dr. Shanahan served as Chief Medical Officer for Tanox, Inc., a biopharmaceutical company. From October 1994 to August 2000, Dr. Shanahan held various positions at Isis Pharmaceuticals, Inc., a biopharmaceutical company, most recently as Vice President, Drug Development. From 1989 to 1994, Dr. Shanahan served as Director, Clinical Research for Pfizer Central Research, a pharmaceutical company. From 1986 to 1989, Dr. Shanahan held various positions at Searle Research & Development, a pharmaceutical company subsequently acquired by Pfizer, most recently as Director, Clinical Research. Dr. Shanahan holds an A.B. from Dartmouth College, an M.D. from the University of California, San Francisco and a J.D. from Loyola University, Chicago.

Organization Position Status
Arena Pharmaceuticals, Inc. Vice President & Chief Medical Officer Current
Merchant Advisory Group (Mag) Board of Directors Current
Olink Board of Directors Current
Industry Ventures Board of Directors Current
IDEXX Laboratories, Inc. Board of Directors Current
Diageo plc Board of Directors Current
Resgen Inc. Board of Directors Current
Pittsburgh Tissue Engineering Initiative, Inc Board of Directors Current
Microseq Board of Directors Current
Merchant Advisory Group (Mag) Committee Member Current
Colgate-Palmolive Company President Former
Tanox, Inc. Chief Medical Officer Former
Isis Pharmaceuticals, Inc. Vice President Former
Pfizer Inc. Director Former
The University of California, San Francisco M.D. Former
Loyola University J.D. Former
University of California, San Francisco M.D. Former
Dartmouth College Bachelor of Arts Degree In Geography Former

Steven W. Spector, J.D., has served as our Senior Vice President and General Counsel since June 2004. Mr. Spector served as our Vice President and General Counsel from October 2001 to June 2004. Mr. Spector has also served as our Secretary since November 2001. Mr. Spector is a member of the board of directors and the immediate-past President of the Association of Corporate Counsel, San Diego. Prior to joining Arena, Mr. Spector was a partner with the law firm of Morgan, Lewis & Bockius LLP, where he worked from 1991 to October 2001. Mr. Spector was a member of the Morgan Lewis Technology Steering Committee. Mr. Spector was our outside corporate counsel from 1998 to October 2001. Mr. Spector holds a B.A. and a J.D. from the University of Pennsylvania.

Organization Position Status
Arena Pharmaceuticals, Inc. Senior Vice President, General Counsel and Secretary Current
A-R-E-N-A.Com Current
Arena Pharmaceuticals, Inc. Secretary Current
Chemnavigator.Com, Inc. Director Former
University of Pennsylvania B.A. and A J.D. Former

K.A. Ajit-Simh has served as our Vice President, Quality Systems since January 2004. Mr. Ajit-Simh provided regulatory compliance services to several companies in the United States and internationally from 1999 to the end of 2003. Mr. Ajit-Simh held various positions of increasing responsibility at Mallinckrodt Inc. from 1975 to 1985, Baxter Healthcare from 1986 to 1989, Abbott BioTech from 1989 to 1992, and Cytel Corporation from 1992 to 1999. In addition, he has been an instructor at the University of California, San Diego since 1994, teaching classes in regulatory compliance and quality control/assurance. He also teaches courses in Good Manufacturing Practices and Advanced Quality Control and Assurance at San Diego State University as part of the graduate program in Regulatory Affairs. Mr. Ajit-Simh received a B.Sc. degree in Biology and Chemistry from Bangalore University and an M.S. in Cell Biology from St. Louis University.

Organization Position Status
Arena Pharmaceuticals, Inc. Vice President, Quality Sys Current

Organization Position Status
Arena Pharmaceuticals, Inc. Vice President, Quality Systems Current

Organization Position Status
Arena Pharmaceuticals, Inc. Vice President, Business Development & Marketing Current

Organization Position Status
Arena Pharmaceuticals, Inc. Vice President, Marketing and Business Development Current
Ligand Pharmaceuticals Incorporated Executive Director Former
University of Pennsylvania B.S.E. In Biomedical Engineering Former

Organization Position Status
Cara Therapeutics Inc. Chief Executive Officer, President, and Director Current
Arena Pharmaceuticals, Inc. Co-Founder Current
Cara Therapeutics Inc. Co-Founder Current
Cara Therapeutics Inc. Board of Directors Current
A-R-E-N-A.Com Vice President Former
A-R-E-N-A.Com Executive Director Former
Neurocrine Biosciences, Inc. Principal Investigator Former

Organization Position Status
Arena Pharmaceuticals, Inc. Director, Corporate Communications Current
Arena Pharmaceuticals, Inc. Board of Directors Current

Organization Position Status
Arena Pharmaceuticals, Inc. Current
University of California, Los Angeles professor of Economics Former
Micromet, Inc. member Former
University of California, Los Angeles Chairman Former
University of California, Los Angeles Ph.D. in Economics Former

Organization Position Status
Arena Pharmaceuticals, Inc. Current

Organization Position Status
Novarx Corporation Member of the Novarx Scientific Advisory Board Current
Arena Pharmaceuticals, Inc. Board of Directors Current
Arena Pharmaceuticals, Inc. Member Current
Sidney Kimmel Cancer Center Director of Clinical Oncology Research Former
Biogen Idec, Inc. Former
Department of Medicine Chair Former
Sidney Kimmel Cancer Center Chairman Former
University of Chicago M.D. Former
University of Chicago B.A In Biology Former
University of Chicago Degree Former

Organization Position Status
Arena Pharmaceuticals, Inc. Director Current

Array

Organization Position Status
Sequenom, Inc. Chairman of the Board of Directors Current
San Diego Opera Member of the Board Current
Discovery Partners International, Inc. Board of Directors Current
Signal Pharmaceuticals, LLC Director Current
Arena Pharmaceuticals, Inc. Director Current
Infinity Pharmaceuticals, Inc Director Current
Arena Pharmaceuticals, Inc. Member Current
Braincells, Inc. Chief Executive Officer Former
Amgen Inc. President and Chief Operating Officer and Member Former
Braincells, Inc. Co-Founder Former
Abbott Laboratories Former
Discovery Partners International, Inc. Chairman Former
Sequenom, Inc. Board of Directors Current
University of Chicago M.B.A. Former
Purdue University B.S. In Chemical Engineering Former
Amgen Inc. Member Former

J. Clayburn La Force, Jr., Ph.D., has served as a member of our Board of Directors since October 2002. Dr. La Force served as a professor of Economics at the University of California, Los Angeles from 1962 to 1978, and served as Dean of the Anderson School of Management at the University of California, Los Angeles from July 1978 to June 1993. From 1969 to 1978, Dr. La Force served as the Chairman of the Economics Department at the University of California, Los Angeles. Dr. La Force formerly severed on a number of boards of directors, including for the following registered investment companies: Payden Funds, Metzler Payden, and Advisors Series Trust. Dr. La Force holds an A.B. in Economics from San Diego State College and an M.A. and a Ph.D. in Economics from the University of California, Los Angeles.

Organization Position Status
Arena Pharmaceuticals, Inc. Director Current
University of California, Los Angeles Professor Former
University of California, Los Angeles Ph.D. In Economics Former
University of California PH.D. In Economics Former
University of California, Los Angeles M.A. In Economics Former
University of California M.A. Former
University of California A.B. In Economics Former

Organization Position Status
Targegen, Inc. Board of Directors Current
Arena Pharmaceuticals, Inc. Board of Directors Current
Gen-Probe Inc. Board of Directors Current
Mlt Research Limited Director Current
Micromet, Inc. Board of Directors Current
Idec Pharmaceuticals Corporation Chief Financial Officer Former
Idec Pharmaceuticals Corporation Senior Vice President Former
Gen-Probe Inc. Chair Former
University of Southern California M.B.A. Former
University of Southern California M.B.A. Former
University of California B.S. In Biochemistry Former
University of California, Davis B.S. In Biochemistry Former

Organization Position Status
Novacardia, Inc President and Chief Executive Officer Current
Sequel Pharmaceuticals, Inc. President and CEO Current
Bente Hansen & Associates President Current
Biocom, Inc. Chairman of The Board of Directors Current
Sequel Pharmaceuticals, Inc. Member of The Board of Directors Current
Bente Hansen & Associates Board of Directors Current
Arena Pharmaceuticals, Inc. Board of Directors Current
Novacardia, Inc Board of Directors Current
Corvas International, Inc. Chief Executive Officer Former
NovaCardia, Inc. Chief Executive Officer Former
NovaCardia, Inc. President Former
Boehringer Mannheim Vice President of Marketing and Sales Former
Eli Lilly and Company Former
Sequel Former
Biocom, Inc. Board of Directors Former
Western Michigan University M.B.A. Former
Ball State University B.S. Degree In Biology Former

Organization Position Status
Arena Pharmaceuticals, Inc. Board of Directors Current

Organization Position Status
Arena Pharmaceuticals, Inc. Board of Directors Current
Selective Genetics Chief Operating Officer Former
Nanogen, Inc. Co-Founder Former
Hybritech, Inc. Former
University of California, Irvine B.S. In Biological Sciences Former

Timothy M. Buono has served on our board of directors since March 2000. Mr. Buono is a founder and member of Aura Equity Partners, LLC, a private equity firm focused on growth oriented investments in companies within the consumer driven health and personal care markets. Mr. Buono previously served as vice-president of Tullis-Dickerson & Co., Inc. from 1997 to 2008, a healthcare focused venture capital firm. During this time, he was also a partner in the general partner entities of its sponsored venture capital funds. From 1994 to 1997, he served as senior vice president, business development, for Health Partners, Inc., a healthcare services company. From 1993 to 1994, Mr. Buono served as director, business development, for Occupational Health Resources, Inc., a healthcare services company. From 1990 to 1993, Mr. Buono served as an associate of Tullis-Dickerson & Co., Inc. From 1988 to 1990, Mr. Buono was a financial and operations analyst for Shaffer-Clarke. Mr. Buono is a director of a number of privately-held companies. He received his B.A. in Economics from Connecticut College in 1988, and completed an Executive Program at Columbia University’s Graduate School of Business in 2003.

Organization Position Status
Genoptix, Inc. President, Chief Executive Officer Current
University of San Diego Board of Directors Current
UCSD-CONNECT Director Current
Cyntellect, Inc. Member of the Company's Board of Directors Current
Cypress Bioscience, Inc. Board of Directors Current
Heska Corporation Director Current
Biocom, Inc. Executive Board Member Current
Arena Pharmaceuticals, Inc. Director Current
Arena Pharmaceuticals, Inc. Member Current
Nanogen, Inc. Chief Operating Officer and President Former
Selective Genetics Chief Operating Officer Former
Ligand Pharmaceuticals Incorporated Executive Director Former
Nanogen, Inc. Co-Founder Former
Genoptix, Inc. Co-Founder Former
Hybritech, Inc. Former
University of California PH.D. In Biochemistry Former
University of California, Riverside Ph.D. Degree In Biochemistry Former
University of California, Irvine B.S. In Biological Sciences Former
Cyntellect, Inc. Member Former
Heska Corporation member Former

Mr. Belcher has served as a member of our Board of Directors since December 2003. Mr. Belcher served as Chairman of the Board of Directors of Banta Corporation, a printing and supply-chain management company, from May 1995 to April 2004, Chief Executive Officer from January 1995 to October 2002 and President from September 1994 to January 2001. Mr. Belcher holds a B.A. from Dartmouth College and an M.B.A. from the Stanford University Graduate School of Business.

Organization Position Status
Arena Pharmaceuticals, Inc. Member Current
Arena Pharmaceuticals, Inc. Director Current
Banta Corporation Chairman of the Board of Directors Former
Stanford University M.B.A. Former
Dartmouth College B.A. Former

Scott H. Bice has served as a member of our Board of Directors since December 2003. Since June 2000, Mr. Bice has been the Robert C. Packard Professor at the University of Southern California Law School, where he served as Dean from 1980 to June 2000. Mr. Bice has experience on several corporate boards, including Imagine Films, from 1992 to 1994, Western and Residence Mutual Insurance Companies, from 1996 to 2003, and Jenny Craig, from 1996 to 2002. Mr. Bice holds a B.S. in finance and a J.D. from the University of Southern California.

Organization Position Status
Arena Pharmaceuticals, Inc. Member Current
Arena Pharmaceuticals, Inc. Director Current
University of Southern California School of Law Professor Former
University of Southern California J.D. Former

Executive News

  • Genoptix: Adding Physicians, Growing Revenue

    Seeking Alpha - 8/12/09 - View Story

advertisement
     ARNA $3.54 -0.10 (-2.75% )
Average Volume 5,296,380
Shares Outstanding 92.72M
Market Cap 328.2M
Year High 7.42
Year Low 2.26
Earnings Per Share -2.38
P/E Ratio -1.49
Dividend N/A
Yield N/A
advertisement
Click Here